The Seeking Alpha community mourns the sudden and premature death of SA contributor Joe Feshbach. Joe suffered a fatal heart attack Friday, August 12, 2011 while riding his bicycle. Our thoughts are with Joe's loved ones at this time. May he rest in peace. ------------------------- Joseph L. Feshbach had over 25 years of professional investment experience, both long and short. Additionally he was Chairman and CEO of a publicly traded healthcare services company with a large wound care services business, and has served on multiple public and private company boards. He served as CIO of his family office, Joe Feshbach Partners LLC.
After years of playing mind games at Langley, I am using my company connections to score big time in the stock market. I am Grand Phatmanotoo at the secret OTO Lodge of the Midwest north of Omaha, NE. I've done extensive banking at the former Franklin Community Federal Credit Union in North Omaha that helped support our fighting men and women in Central America am South Central Los Angeles in the '80s.
Brian Marckx, CFA is the Senior Medical Device / Diagnostics Analyst with Zacks Investment Research. I cover small and micro-cap medical device and diagnostic companies. Focus is development-stage companies with novel and emerging technologies as well as already established names still flying under the radar.
Prior to joining Zacks, Brian worked as a high-yield bond analyst on Wachovia Securities’ institutional trading desks where he specialized in the healthcare and industrials industries. Prior to that he was an analyst in corporate finance at First Union National Bank. Brian has covered the medical device, pharmaceutical and biotechnology industries since joining Zacks.
Brian has been quoted in numerous publications including The Wall Street Journal, Barron's, Bloomberg-Businessweek and Kiplinger. His work has also been cited in various market studies and working papers including those from Massachusetts Institute of Technology, Deloitte & Touche, and Pharmaceutical Manufacturing. Brian graduated with a B.S. in Finance from St. John Fisher College and received his MBA from Wake Forest University. Brian is also a Chartered Financial Analyst charterholder.
Have been an investor for 60 years. Last 20 years have concentrated on biotechs. Have been senior exec with Shell and ITT before retiring 30+ years ago. My working areas were finance, informatics and international management. Taught MBA courses in management, informatics and communications. Speak French and Spanish plus some German.